chronic spontaneous urticaria epidemiology forecast insight

DelveInsight’s ‘Chronic Spontaneous Urticaria–Epidemiology Forecast—2034’ report delivers an in-depth understanding of Chronic Spontaneous Urticaria, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

• The United States
• EU5
• Japan

Chronic Spontaneous Urticaria Disease Understanding

Chronic urticaria is a debilitating disease characterized by itching and hives with or without angioedema lasting for more than 6 weeks. Chronic Spontaneous Urticaria (CSU) results from pathogenic activation of mast cells and basophils, which gives rise to the release of proinflammatory mediators that support the generation of urticaria.

The autoimmune pathogenesis of chronic urticaria including recent data suggests that CSU may involve contributions from both immunoglobin G (IgG)-specific and immunoglobulin E (IgE)-specific autoantibodies against a vast array of antigens that can span beyond those found on the surface of mast cells and basophils

Chronic spontaneous urticaria (CSU) is a distressing skin condition that causes red, swollen, itchy and sometimes painful hives or “wheals” on the skin. Lesions can be as small as a few millimeters in diameter but can coalesce to form ‘wheals’ as large as several centimeters wide. They often remit within 24 h since the time of onset.

Chronic Spontaneous Urticaria Epidemiology

The Chronic Spontaneous Urticaria epidemiology division provides insights into the historical and current patient pool and the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends and assumptions.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted Chronic Spontaneous Urticaria epidemiology segmented as the Total Prevalent cases of Chronic Spontaneous Urticaria, Gender-Specific Cases of Chronic Spontaneous Urticaria, Age-specific cases of Chronic Spontaneous Urticaria. The report includes the prevalent Chronic Spontaneous Urticaria symptoms in 7MM covering the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2021 to 2034.

Country-wise Chronic Spontaneous Urticaria Epidemiology

The epidemiology segment also provides the Chronic Spontaneous Urticaria epidemiology data and findings across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

• The total prevalent population of Chronic Spontaneous Urticaria associated in the 7MM was estimated to be 1,842,594 in 2020 and expected to increase for the study period, i.e., 2021-2034.
• Among the EU5 countries, Germany had the highest prevalent population of Chronic Spontaneous Urticaria followed by France.

Scope of the Report

• Chronic Spontaneous Urticaria report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Chronic Spontaneous Urticaria Epidemiology Report and Model provide an overview of the risk factors and global trends of Chronic Spontaneous Urticaria in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report provides insight into the historical and forecasted patient pool of Chronic Spontaneous Urticaria in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Chronic Spontaneous Urticaria
• The report provides the segmentation of the Chronic Spontaneous Urticaria epidemiology by Prevalent Cases of Chronic Spontaneous Urticaria in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan
• The report provides the segmentation of the Chronic Spontaneous Urticaria epidemiology by severity-specific Prevalent Cases of Chronic Spontaneous Urticaria in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan

Report Highlights

• 10-year Forecast of Chronic Spontaneous Urticaria epidemiology
• United States Coverage
• Total Prevalent Cases of Chronic Spontaneous Urticaria
• Prevalent Cases according to segmentation: Type-specific Prevalence of Chronic Spontaneous Urticaria

KOL Views

We interview KOLs, and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about Chronic Spontaneous Urticaria?
• What are the key findings of Chronic Spontaneous Urticaria epidemiology across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan and which type will have the highest number of patients during the forecast period (2021-2034)?
• What would be the total number of patients with Chronic Spontaneous Urticaria across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan during the forecast period (2021-2034)?
• At what CAGR the patient population is expected to grow during the forecast period (2021-2034)?
• What are the disease risk, burden, and unmet needs of Chronic Spontaneous Urticaria?
• What are the currently available treatments for Chronic Spontaneous Urticaria?

Reasons to buy

The Chronic Spontaneous Urticaria Epidemiology report will allow the user to -

• Develop business strategies by understanding the trends shaping and driving the global Chronic Spontaneous Urticaria market
• Quantify patient populations in the global Chronic Spontaneous Urticaria market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Chronic Spontaneous Urticaria therapeutics in each of the markets covered
• Understand the magnitude of Chronic Spontaneous Urticaria population by its Prevalence cases
• Understand the magnitude of Chronic Spontaneous Urticaria population by its Type-specific cases
• The Chronic Spontaneous Urticaria epidemiology report and model was written and developed by Masters and PhD level epidemiologists
• The Chronic Spontaneous Urticaria Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population